Skip to main content

Morning Bell 13 April

Jessica Amir
April 13, 2021

Vaccine talks will dominate local headlines today for two reasons – the Federal government has taken the J&J vaccine off the table and ScoMo has said that Aussies will likely not receive a vaccine by the end of year.

This means travel and tourism stocks will be back in focus, in particular Qantas (ASX:QAN), as the company planned to initially resume international flights in October as Australians were initially set to be vaccinated by then.

 What to watch today:  

  • The Aussie market is expected to rise 0.2% if the futures are correct.
  • New home sales and business confidence data out today.
  • Keep an eye on the most traded stocks from yesterday. For our active trader desk, Bell Direct Advantage they were: Delorean (ASX:DEL) which listed on the ASX on Monday, and Digital Wine Ventures (ASX:DW8).

Trading ideas:

  • The a2Milk Company (ASX:A2M) was upgraded from a Hold to a Buy with an increased price target of $9.50 as China distribution is showing strong signs of early life.
  • Macquarie rated Dexus (ASX:DXS) as a Buy with a $10.33 target and an estimated dividend yield of 4.53%.
  • Galan Lithium (ASX:GLN), Mach7 Technologies (ASX:M7T), People Infrastructure (ASX:PPE) are all giving off bullish charting signals according to Trading Central.

Superannuation Reforms

Bell Direct
January 16, 2017

Market Update

Julia Lee
January 16, 2017

Market Update

Julia Lee
January 13, 2017

Market Update 12 Jan

Julia Lee
January 12, 2017

Market Update

Julia Lee
January 11, 2017

Market Update

Julia Lee
January 9, 2017

Market Update

Julia Lee
January 6, 2017

Market Update

Julia Lee
January 5, 2017

Market Update

Julia Lee
December 23, 2016

Market Update

Julia Lee
December 22, 2016

Stock Rankings 2017 – Bell Potter

Bell Direct
December 22, 2016